Nailesh Bhatt

Filings by Nailesh Bhatt span 2 companies, the busiest being Sonnet BioTherapeutics Holdings, Inc. and Hyperliquid Strategies Inc. We count 13 filings; the first trade dates from 1 April 2020 and the latest from 1 October 2026.

Purchases make up the whole of the open-market record (1 purchase, €5,351). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 10 share grants.

Most recently, on 15 October 2026, the filings show a share grant in Hyperliquid Strategies Inc. The last insider purchase was made public on 18 May 2023, 1,255 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.